Skip to main content

FHI (Fenofibrate 120 mg)

Pill with imprint FHI is White, Elliptical/Oval and has been identified as Fenofibrate 120 mg. It is supplied by Global Pharmaceutical Corporation.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iib, elevated ldl vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 120 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for FHI


120 mg
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Global Pharmaceutical Corporation
Inactive Ingredients
lactose monohydrate, polyethylene glycol 6000, poloxamer 188, magnesium stearate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00115-1523 Global Pharmaceuticals
68012-0495 Santarus, Inc.

Get help with Imprint Code FAQs.

Related images for "FHI"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.